Chronicgastritis classifications

##plugins.themes.academic_pro.article.sidebar##

Published Oct 8, 2018
Download
pdf
Vol. 96 No. 7 (2018): Issue Jul 2018

##plugins.themes.academic_pro.article.main##

Dhouha Bacha
Marwa Walha
Sana Ben Slama
Haifa Ben Romdhane
Saadia Bouraoui
Khadija Bellil
Ahlem Lahmar

Abstract

Chronic gastritis are inflammatory diseases of the gastric mucosa whose diagnosis depends on  pathological examination.
They are frequent and cover a significant part of the daily activity of pathologists. Their origin is often infectious, particularly by Helicobacter Pylori.
Several classifications of chronic gastritis were proposed but in order to achieve standardization in the drafting of pathological reports of gastric biopsies, pathologists currently following the recommendations of the revisted Sydney System.
OLGA (Operative Link for Gastritis Assessment) and OLGIM (Operative Link for Gastritis Intestinal metaplasia Assessment) stages are increasingly used since they allow the clinicians to select patients with « high risk » chronic gastritis, which require special monitoring.
The aim of this paper was to perform a review of the different classifications of chronic gastritis currently available to pathologists.

Keywords:

Gastritis; atrophy, intestinal metaplasia, classifications

##plugins.themes.academic_pro.article.details##

References

  1. Valencia-Parparcen J, Carbonell L, Bruni-Celli B, Madureri V. Diagnosis of gastritis: a review and a report of the use of blind biopsy. Am J Dig Dis 1961;6:813‑32.
  2. Misiewicz JJ. The Sydney System: a new classification of gastritis. Introduction. J Gastroenterol Hepatol 1991;6(3):207‑8.
  3. Whitehead R, Truelove SC, Gear MW. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972;25(1):1‑11.
  4. Lambert R. Chronic gastritis. A critical study of the progressive atrophy of the gastric mucosa. Digestion 1972;7(1):83‑126.
  5. Schindler R. What does gastroscopy offer in the early diagnosis of cancer of the stomach? Calif Med 1947;66(3):110‑6.
  6. Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973;18(5):426‑40.
  7. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988;83(5):504‑9.
  8. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1(8336):1273‑5.
  9. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6(3):209‑22.
  10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20(10):1161‑81.
  11. Dixon MF, Genta RM, Yardley JH, Correa P. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997;2(1 Suppl):17-24.
  12. Varbanova M, Wex T, Jechorek D, Röhl FW, Langner C, Selgrad M, et al. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment. J Clin Pathol 2016;69(1):19‑25.
  13. Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Funka K, Kikuste I, et al. The effect of incisura angularis biopsy sampling on the assessment of gastritis stage. Eur J Gastroenterol Hepatol 2014;26(5):510‑3.
  14. Rokkas T, Rokka A, Portincasa P.A systematic review and meta-analysis of the role of Helicobacter Pylori eradication in preventing gastric cancer.Ann Gastroenterol. 2017;30(4):414-23
  15. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44(1):74‑94.
  16. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40(8):650‑8.
  17. Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71(7):1150‑8.
  18. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16(7):1249‑59.
  19. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010;31(10):1104‑11.
  20. Offerhaus GJ, Price AB, Haot J, ten Kate FJ, Sipponen P, Fiocca R, et al. Observer agreement on the grading of gastric atrophy. Histopathology 1999;34(4):320‑5.
  21. Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, et al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011;17(41):4596‑601.
  22. Zhou Y, Li H-Y, Zhang J-J, Chen X-Y, Ge Z-Z, Li X-B. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol 2016;22(13):3670‑8.
  23. Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Putnins V, Funka K, et al. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch 2014;464(4):403‑7.
  24. Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, Wen X, Lopes C, Figueiredo C, et al. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012;35(12):1451‑9.
  25. Satoh K, Osawa H, Yoshizawa M, Nakano H, Hirasawa T, Kihira K, et al. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008;13(3):225‑9.
  26. Gurzu S, Orlowska J, Sugimura H, Bara T, Szentirmay Z, Januszewicz W, Bara T Jr, Szederjesi J, Jung I. Immunohistochemical features and staging of early gastric cancer.Arch Med Sci 2017;13(6):1373-82.
  27. den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, Ter Borg F, et al. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy 2013;45(4):249‑56.